Advanced HER2-positive breast cancer: Overcoming treatment resistance

被引：0
|
作者：
Rimawi, M. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-ES1-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES1-3
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The changing treatment of metastatic her2-positive breast cancer
    Mitsogianni, Maria
    Trontzas, Ioannis P.
    Gomatou, Georgia
    Ioannou, Stephanie
    Syrigos, Nikolaos K.
    Kotteas, Elias A.
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [42] Role of pertuzumab in the treatment of HER2-positive breast cancer
    Hubalek, Michael
    Brantner, Christine
    Marth, Christian
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 65 - 73
  • [43] Optimizing treatment of HER2-positive metastatic breast cancer
    Jones, AL
    Leyland-Jones, B
    SEMINARS IN ONCOLOGY, 2004, 31 (05) : 29 - 34
  • [44] Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    Geyer, Charles E.
    Forster, John
    Lindquist, Deborah
    Chan, Stephen
    Romieu, C. Gilles
    Pienkowski, Tadeusz
    Jagiello-Gruszfeld, Agnieszka
    Crown, John
    Chan, Arlene
    Kaufman, Bella
    Skarlos, Dimosthenis
    Campone, Mario
    Davidson, Neville
    Berger, Mark
    Oliva, Cristina
    Rubin, Stephen D.
    Stein, Steven
    Cameron, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2733 - 2743
  • [45] Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
    Li, Yan
    Ma, Xiaoping
    Zhao, Zhenhui
    Li, Li
    Gao, Chunyan
    Liu, Dan
    Li, Bingyu
    Zhao, Bing
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 405 - 415
  • [46] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [47] New developments in the treatment of HER2-positive breast cancer
    Nahta, Rita
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 53 - 64
  • [48] HER2-positive breast cancer: Current treatment strategies
    Perez, Edith A.
    Baweja, Mansoina
    CANCER INVESTIGATION, 2008, 26 (06) : 545 - 552
  • [49] Margetuximab for the treatment of HER2-positive metastatic breast cancer
    Tarantino, Paolo
    Morganti, Stefania
    Uliano, Jacopo
    Giugliano, Federica
    Crimini, Edoardo
    Curigliano, Giuseppe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (02) : 127 - 133
  • [50] Optimal Perioperative Treatment for HER2-Positive Breast Cancer
    Matsuzaki, H.
    Sakata, H.
    Aoyagi, T.
    Namura, M.
    Tamanuki, T.
    Iwai, M.
    Sasahara, N.
    Mizuuchi, S.
    BREAST, 2025, 80
12345